ORIC ▲ +2.4% - ORIC Pharmaceuticals, Inc. $ORIC - ORIC® Pharmaceuticals Announces Agreement with Cancer Research UK to Advance a Potential First-in-Class CIP2A-Targeted Therapy Into Clinical Development 05-OCT-2026 04:01 PM ET